tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
LivaNova Shareholders Approve Key Incentive Plans at AGM
PremiumCompany AnnouncementsLivaNova Shareholders Approve Key Incentive Plans at AGM
2M ago
LivaNova’s Strong Growth Potential Driven by Product Innovation and Market Expansion
Premium
Ratings
LivaNova’s Strong Growth Potential Driven by Product Innovation and Market Expansion
2M ago
LivaNova publishes 24-month data from CORE-VNS study in Epilepsia
Premium
The Fly
LivaNova publishes 24-month data from CORE-VNS study in Epilepsia
2M ago
Bullish Outlook for LivaNova: Growth in Cardiopulmonary and Epilepsy Segments with Promising Pipeline
PremiumRatingsBullish Outlook for LivaNova: Growth in Cardiopulmonary and Epilepsy Segments with Promising Pipeline
3M ago
LivaNova upgraded to Outperform from Peer Perform at Wolfe Research
Premium
The Fly
LivaNova upgraded to Outperform from Peer Perform at Wolfe Research
3M ago
LivaNova’s Resilience: Buy Rating Affirmed Amid Temporary Setbacks and Future Growth Prospects
Premium
Ratings
LivaNova’s Resilience: Buy Rating Affirmed Amid Temporary Setbacks and Future Growth Prospects
3M ago
LivaNova’s Strong Q1 2025 Performance and Positive Outlook Justify Buy Rating
PremiumRatingsLivaNova’s Strong Q1 2025 Performance and Positive Outlook Justify Buy Rating
3M ago
LivaNova lowers 2025 adjusted EPS view to $3.60-$3.70 from $3.65-$3.75
Premium
The Fly
LivaNova lowers 2025 adjusted EPS view to $3.60-$3.70 from $3.65-$3.75
3M ago
LivaNova reports Q1 adjusted EPS 88c, consensus 76c
Premium
The Fly
LivaNova reports Q1 adjusted EPS 88c, consensus 76c
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100